✦ LIBER ✦

Anastrozole Plus Trastuzumab Prolongs Progression-Free Survival in Postmenopausal Patients with HER2-Positive and Hormone Receptor–Positive Metastatic Breast Cancer: A Review of the TAnDEM Study

✍ Scribed by Basi, Sanraj K.; Mackey, John R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized trial of combination anastr

✍ Robert W. Carlson, Anne O’Neill, Tatiana Vidaurre, Henry L. Gomez, Sunil S. Badv 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 275 KB

Phase II evaluation of the efficacy and

✍ J. Cortes; K. Gelmon; P. Fumoleau; A. Wardley; S. Verma; P.F. Conte; L. Gianni; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB

490 Long term survival and incidence of

✍ V. Diéras; M.N. Guilhaume; M. Fall; J.Y. Pierga; P. Beuzeboc; P. Cottu; C. Simon 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Do HER-2 positive metastatic breast canc

✍ Alessandra Fabi; Giulio Metro; Gianluigi Ferretti; Diana Giannarelli; Serena Di 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Everolimus in Combination with Exemestan

✍ Sohita Dhillon 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 426 KB

Fulvestrant plus anastrozole or placebo

✍ Johnston, Stephen RD; Kilburn, Lucy S; Ellis, Paul; Dodwell, David; Cameron, Dav 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 459 KB